logo

For the Inventor, By the Inventor

Toronto, Canada

Apotex Technologies Inc.

Calculating rank
USPTO Granted Patents = 13

% Expired Patents = 69.2



Trademarks = 13

Forward Citations = 17

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Tim Fat Tam (12 out of 33 patents)

silverMedal Yingsheng Wang (12 out of 17 patents)

bronzeMedal Yanqing Zhao (12 out of 17 patents)

4.  Regis C Leung-Toung (11 out of 19 patents)

5.  Blaise N'Zemba (9 out of 10 patents)

6.  Lily Yu (8 out of 9 patents)

7.  Jolanta Maria Wodzinska (2 out of 4 patents)

8.  Maryna Premyslova (2 out of 2 patents)

9.  Tao Xin (2 out of 29 patents)

10.  Birenkumar Hasmukhbhai Shah (2 out of 6 patents)

11.  Michael Spino (1 out of 11 patents)

12.  Anita Hui (1 out of 1 patent)

13.  Cihua Yang (1 out of 1 patent)

14.  Mohammed N Kabir (1 out of 1 patent)

15.  Blaise N′Zemba (1 out of 1 patent)


13 patents:

1. 9550733 - Fluorinated derivatives of 3-hydroxypyridin-4-ones (2017-01-24),
2. 9073865 - Fluorinated derivates of 3-hydroxypyridin-4-ones (2015-07-07),
3. 8735602 - Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture (2014-05-27),
4. 8703156 - Liquid formulation for deferiprone with palatable taste (2014-04-22),
5. 8673943 - Fluorinated derivatives of deferiprone (2014-03-18),
6. 8664262 - Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan (2014-03-04),
7. 8592607 - Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan (2013-11-26),
8. 8507449 - Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan (2013-08-13),
9. 8481588 - Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan (2013-07-09),
10. 8476235 - Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan (2013-07-02),
11. 8207217 - Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan (2012-06-26),
12. 8119606 - Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan (2012-02-21),
13. 8026261 - Fluorinated derivatives of deferiprone (2011-09-27),
Company Overview
Apotex Technologies Inc., based in Toronto, Canada, is a prominent player in the pharmaceutical industry, specializing in the development and manufacturing of generic medications. The company focuses on delivering high-quality, affordable alternatives to branded drugs, thereby enhancing patient access to essential therapies. With a commitment to innovation, Apotex invests in research and development across various therapeutic areas, ensuring a robust pipeline of products that meet global healthcare needs.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

13 Patents

#118 in Toronto

#1,167 in Canada

#45,104 in the World

Toronto, CA
Toronto, Canada

Apotex Technologies Inc.

Forward Citations = 17

16 inventors:

goldMedal Tim Fat Tam (12 out of 33 patents)

silverMedal Yingsheng Wang (12 out of 17 patents)

bronzeMedal Yanqing Zhao (12 out of 17 patents)

4.  Regis C Leung-Toung (11 out of 19 patents)

5.  Blaise N'Zemba (9 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Apotex Technologies Inc.. Retrieved from https://idiyas.com/company/apotex-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…